Table 2.
Hazard ratio | 95% CI | |
---|---|---|
TDF vs. NRTI use | 1.04 | 0.68–1.59 |
Age >45 years | 2.31 | 1.44–3.69 |
Race (black) | 1.52 | 0.85–2.72 |
CD4 cell count <200 cells/μl (baseline) | 2.66 | 1.65–4.29 |
Hypertension | 1.56 | 1.00–2.45 |
PI/r | 2.14 | 1.37–3.34 |
CI, confidence interval; NRTI, nucleoside reverse transcriptase inhibitor; PI/r, ritonavir-boosted protease inhibitor; TDF, tenofovir disoproxil fumarate.